In conclusion, we successfully applied an unbiased, high‐throughput imaging approach and identified a large number of candidate suppressors of mitochondrial dysfunction in MD patient‐derived fibroblasts, none of which are known to be implicated in the modulation of clinical or biochemical severity caused by OPA1 mutations. Here, OPA1 is linked to Menkes disease.